Author Question: A patient is being actively treated for increased intracranial pressure (ICP) in the neurological ... (Read 203 times)

codyclark

  • Hero Member
  • *****
  • Posts: 538
A patient is being actively treated for increased intracranial pressure (ICP) in the neurological intensive care unit. The patient's current plan of care includes pharmacological interventions to reduce cellular metabolic demand.
 
  The nurse should be aware that this may involve the administration of:
  A) Barbiturates
  B) Benzodiazepines
  C) Anticholinergics
  D) Beta-adrenergic blockers

Question 2

A patient with pheochromocytoma has been admitted for an adrenalectomy tomorrow. The patient is to start IV medication this evening to prevent adrenal insufficiency. What medication is the patient most likely to require?
 
  A) Antibiotics
  B) Antihypertensives
  C) Parenteral nutrition
  D) Corticosteroids



peter

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

A

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

The most common childhood diseases include croup, chickenpox, ear infections, flu, pneumonia, ringworm, respiratory syncytial virus, scabies, head lice, and asthma.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library